Paul Y. Song, Chief Executive Officer at NKGen Biotech, Inc. (NKGN), bought 267 shares at $3.33 ($850) on 2023-12-05, disclosed to the SEC on 2023-12-05.
Open-market purchase of $850 NKGN by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.07 | 162 | $500 | 58.8% |
| 2 | $3.33 | 105 | $350 | 41.2% |
| Total | $3.18 avg | 267 | $850 | 100% |
| Filing → |
| NKGN | BUY | 2023-11-28 | $701 | — | Filing → |
| NKGN | BUY | 2023-11-22 | $430 | — | Filing → |